Patrick G.  Lepore net worth and biography

Patrick Lepore Biography and Net Worth

Director of Lannett
Patrick G. LePore was appointed as a Director of the Company in July 2017. On July 1, 2018, Mr. LePore succeeded Mr. Farber as Chairman of the Board of Directors. Mr. LePore served as chairman, Chief Executive Officer and president of Par Pharmaceuticals, Inc., until the company’s acquisition by private equity investor TPG in 2012.  He remained as chairman of the new company through the sale of the company to Endo Pharmaceuticals. Mr. LePore began his career with Hoffmann LaRoche.  Later, he founded Boron LePore and Associates, a medical communications company, which he took public and was eventually sold to Cardinal Health.  Mr. LePore is the Vice Chairman of the board of Matinas BioPharm and is a trustee of Villanova University.  Mr. LePore earned his bachelor’s degree from Villanova University and Master of Business Administration from Fairleigh Dickinson University.

What is Patrick G. Lepore's net worth?

The estimated net worth of Patrick G. Lepore is at least $0.00 as of November 15th, 2023. Mr. Lepore owns 36,472 shares of Lannett stock worth more than $0 as of March 18th. This net worth estimate does not reflect any other investments that Mr. Lepore may own. Learn More about Patrick G. Lepore's net worth.

How do I contact Patrick G. Lepore?

The corporate mailing address for Mr. Lepore and other Lannett executives is 9000 STATE ROAD, PHILADELPHIA PA, 19136. Lannett can also be reached via phone at (215) 333-9000. Learn More on Patrick G. Lepore's contact information.

Has Patrick G. Lepore been buying or selling shares of Lannett?

Patrick G. Lepore has not been actively trading shares of Lannett in the last ninety days. Most recently, on Tuesday, February 8th, Patrick G. Lepore bought 12,500 shares of Lannett stock. The stock was acquired at an average cost of $3.52 per share, with a total value of $44,000.00. Learn More on Patrick G. Lepore's trading history.

Who are Lannett's active insiders?

Lannett's insider roster includes Timothy Crew (CEO), Jeffrey Farber (Director), John Kozlowski (CFO), and Patrick Lepore (Director). Learn More on Lannett's active insiders.

Patrick G. Lepore Insider Trading History at Lannett

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/8/2022Buy12,500$3.52$44,000.00View SEC Filing Icon  
11/29/2021Buy12,500$6.84$85,500.00View SEC Filing Icon  
5/11/2021Buy5,000$16.72$83,600.0065,081View SEC Filing Icon  
9/3/2019Buy6,250$39.28$245,500.0050,335View SEC Filing Icon  
2/12/2019Buy6,250$35.72$223,250.00View SEC Filing Icon  
8/31/2018Buy6,250$21.36$133,500.0016,973View SEC Filing Icon  
5/11/2018Buy6,250$60.52$378,250.00View SEC Filing Icon  
See Full Table

Patrick G. Lepore Buying and Selling Activity at Lannett

This chart shows Patrick G Lepore's buying and selling at Lannett by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lannett Company Overview

Lannett logo
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $1.54
Low: $0.65
High: $2.51

2 Week Range

Now: N/A

Volume

280,600 shs

Average Volume

92,067 shs

Market Capitalization

$7.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95